Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by lscfaon Mar 08, 2021 12:13pm
137 Views
Post# 32743631

RE:RE:RE:RE:RE:RBC Initiate Coverage

RE:RE:RE:RE:RE:RBC Initiate Coverage

Zacks and other quants only see official no.s posted on financial websites. No ability to drill down. The COVID impact of 2020 should be viewed as a one time opportunity to raise non-dilutive cash.    

2020 total revenues $131.3M (reported)        
2020 core revenues $96.9M (not reported)      

2021 forecast avg revenues of $116.7M
 



lscfa wrote:

If Zacks issued a sell recommendation why no target price? I think the recommendation is based on short-sighted quantitative analysis and no fundamental analysis. Everyone already knows the comps for this year's quarters will be lower than last year's because of a big COVID spike.  


 

donmayne wrote: Well, we now know who was behind the increased short volume starting late February.

https://shortvolume.com/?t=vmd

It my opinion, it was the Zacks folks who are now seeking to cover their short.  Zacks just issued a sell rating on VMD.  https://www.marketbeat.com/instant-alerts/nyse-vmd-a-buy-or-sell-right-now-2021-03/

In my opinion, their methods are self serving.
   Step 1: Short the stock before and during financial reporting.
   Step 2: On the day of financial reporting, short even more if the stock goes up.
   Step 3: On the next day, short more until it drops and then start covering.  
   Step 4: On the next day, push it down more to try to eliminate momentum. 
   Step 5: Once it settles, cover slowly.
   Step 6: If shorts are losing money, in desparation, issue a SELL rating. 

Recently, Zacks did this to CVE.  Someone had been losing on their shorts and in desparation issued their sell rating on Feb 12. CVE promptly rose 20%.  Shorts covered at a loss.  

In regards to VMD, Zacks issued a BUY rating Oct 21, 2020 and the Zacks followers lost money because VMD missed Q3 expectations. 

Now we have seen someone develop a short position. Then VMD exceeds Q4 expectations significantly. Beacon raises targets and RBC initiates with an outperform rating.  Oh oh...the short position is in trouble. 

I am thinking Zacks is as wrong with their SELL rating as they were with CVE. 

Time will tell!  GLTA.

 

 

 



<< Previous
Bullboard Posts
Next >>